Leah Naomi Mccarty, - Medicare Nurse Practitioner in Sacramento, CA

Leah Naomi Mccarty, is a medicare enrolled "Nurse Practitioner - Family" in Sacramento, California. Her current practice location is 1451 River Park Dr Ste 244, Sacramento, California. You can reach out to her office (for appointments etc.) via phone at (916) 756-7122.

Leah Naomi Mccarty is licensed to practice in California (license number 95024635) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1013601384.

Contact Information

Leah Naomi Mccarty,
1451 River Park Dr Ste 244,
Sacramento, CA 95815-4521
(916) 756-7122
Not Available



Provider's Profile

Full NameLeah Naomi Mccarty
GenderFemale
SpecialityNurse Practitioner - Family
Location1451 River Park Dr Ste 244, Sacramento, California
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1013601384
  • Provider Enumeration Date: 06/08/2023
  • Last Update Date: 06/08/2023
  Medicare PECOS Information:
  • PECOS PAC ID: 3779939087
  • Enrollment ID: I20231023003087

Medical Identifiers

Medical identifiers for Leah Naomi Mccarty such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1013601384NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
363LF0000XNurse Practitioner - Family 95024635 (California)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Leah Naomi Mccarty allows following entities to bill medicare on her behalf.
Entity NameJm Geiss Do Apc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1063825289
PECOS PAC ID: 6103044078
Enrollment ID: O20140919001932

News Archive

FDA issues Complete Response Letter for Teva's Neutroval BLA

Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter for the Biologic License Application (BLA) for Neutrovalâ„¢ (granulocyte colony-stimulating factor) for the reduction in the duration of severe neutropenia and the incidence of febrile neutropenia in patients treated with established myelosuppressive chemotherapy for cancer.

CD74 can serve as prognostic marker for colorectal cancer

CD74 is a protein that is expressed in and on cells of the immune system, such as B lymphocytes and antigen presenting cells. This protein is known for its function in facilitating antigen presentation enabling the immune response. Additionally, Professor Shachar's lab has previously shown that CD74 serves as a survival receptor on cells of the immune system, and that its stimulation by its natural ligand -migration inhibitory factor (MIF)- prevents apoptosis (self destruction) of these cells. It was shown that CD74 is markedly expressed on numerous tumors - hematologic as well as epithelial, and can serve as a prognostic marker. CD74's expression and function on colon intestinal epithelial cells is controversial.

UCSD surgeon first in the U.S. to implant new FDA-approved LINX for GERD

Santiago Horgan, MD, chief of minimally invasive surgery at UC San Diego Health System was the first surgeon in the United States to implant the new FDA-approved LINX for GERD.

Abnormal levels of circulating auto-antibodies found in blood of COPD patients

Moderate to severe chronic obstructive pulmonary disease (COPD) may be an auto-immunity problem, according to researchers in Spain, who studied the presence of auto-antibodies in patients with COPD and compared them to levels of control subjects. They found that a significant number of patients with COPD had significant levels of auto-antibodies circulating in their blood, about 5 to 10 times the level in controls.

Researchers discover mechanism that leads to generation of new nerve cells after stroke

A previously unknown mechanism through which the brain produces new nerve cells after a stroke has been discovered at Lund University and Karolinska Institutet in Sweden. The findings have been published in the journal SCIENCE.

Read more Medical News

› Verified 9 days ago

Entity NameCalifornia Phs Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1649932781
PECOS PAC ID: 2062808645
Enrollment ID: O20220407001048

News Archive

FDA issues Complete Response Letter for Teva's Neutroval BLA

Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter for the Biologic License Application (BLA) for Neutrovalâ„¢ (granulocyte colony-stimulating factor) for the reduction in the duration of severe neutropenia and the incidence of febrile neutropenia in patients treated with established myelosuppressive chemotherapy for cancer.

CD74 can serve as prognostic marker for colorectal cancer

CD74 is a protein that is expressed in and on cells of the immune system, such as B lymphocytes and antigen presenting cells. This protein is known for its function in facilitating antigen presentation enabling the immune response. Additionally, Professor Shachar's lab has previously shown that CD74 serves as a survival receptor on cells of the immune system, and that its stimulation by its natural ligand -migration inhibitory factor (MIF)- prevents apoptosis (self destruction) of these cells. It was shown that CD74 is markedly expressed on numerous tumors - hematologic as well as epithelial, and can serve as a prognostic marker. CD74's expression and function on colon intestinal epithelial cells is controversial.

UCSD surgeon first in the U.S. to implant new FDA-approved LINX for GERD

Santiago Horgan, MD, chief of minimally invasive surgery at UC San Diego Health System was the first surgeon in the United States to implant the new FDA-approved LINX for GERD.

Abnormal levels of circulating auto-antibodies found in blood of COPD patients

Moderate to severe chronic obstructive pulmonary disease (COPD) may be an auto-immunity problem, according to researchers in Spain, who studied the presence of auto-antibodies in patients with COPD and compared them to levels of control subjects. They found that a significant number of patients with COPD had significant levels of auto-antibodies circulating in their blood, about 5 to 10 times the level in controls.

Researchers discover mechanism that leads to generation of new nerve cells after stroke

A previously unknown mechanism through which the brain produces new nerve cells after a stroke has been discovered at Lund University and Karolinska Institutet in Sweden. The findings have been published in the journal SCIENCE.

Read more Medical News

› Verified 9 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Leah Naomi Mccarty is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Leah Naomi Mccarty,
1451 River Park Dr Ste 244,
Sacramento, CA 95815-4521

Ph: (916) 756-7122
Leah Naomi Mccarty,
1451 River Park Dr Ste 244,
Sacramento, CA 95815-4521

Ph: (916) 756-7122

News Archive

FDA issues Complete Response Letter for Teva's Neutroval BLA

Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter for the Biologic License Application (BLA) for Neutrovalâ„¢ (granulocyte colony-stimulating factor) for the reduction in the duration of severe neutropenia and the incidence of febrile neutropenia in patients treated with established myelosuppressive chemotherapy for cancer.

CD74 can serve as prognostic marker for colorectal cancer

CD74 is a protein that is expressed in and on cells of the immune system, such as B lymphocytes and antigen presenting cells. This protein is known for its function in facilitating antigen presentation enabling the immune response. Additionally, Professor Shachar's lab has previously shown that CD74 serves as a survival receptor on cells of the immune system, and that its stimulation by its natural ligand -migration inhibitory factor (MIF)- prevents apoptosis (self destruction) of these cells. It was shown that CD74 is markedly expressed on numerous tumors - hematologic as well as epithelial, and can serve as a prognostic marker. CD74's expression and function on colon intestinal epithelial cells is controversial.

UCSD surgeon first in the U.S. to implant new FDA-approved LINX for GERD

Santiago Horgan, MD, chief of minimally invasive surgery at UC San Diego Health System was the first surgeon in the United States to implant the new FDA-approved LINX for GERD.

Abnormal levels of circulating auto-antibodies found in blood of COPD patients

Moderate to severe chronic obstructive pulmonary disease (COPD) may be an auto-immunity problem, according to researchers in Spain, who studied the presence of auto-antibodies in patients with COPD and compared them to levels of control subjects. They found that a significant number of patients with COPD had significant levels of auto-antibodies circulating in their blood, about 5 to 10 times the level in controls.

Researchers discover mechanism that leads to generation of new nerve cells after stroke

A previously unknown mechanism through which the brain produces new nerve cells after a stroke has been discovered at Lund University and Karolinska Institutet in Sweden. The findings have been published in the journal SCIENCE.

Read more News

› Verified 9 days ago


Nurse Practitioner Nurses in Sacramento, CA

Sumon Johnson, NP
Nurse Practitioner
Medicare: Medicare Enrolled
Practice Location: 2570 48th St, Sacramento, CA 95817
Phone: 916-734-2145    
Sharon Kay Mccoy, FNP
Nurse Practitioner
Medicare: Not Enrolled in Medicare
Practice Location: 2025 Morse Ave, Sacramento, CA 95825
Phone: 916-973-6935    
Frances Eileen Briare, FNP
Nurse Practitioner
Medicare: Not Enrolled in Medicare
Practice Location: 6600 Bruceville Rd, Sacramento, CA 95823
Phone: 916-688-2000    
Ms. Patricia Lynne Kang, GNP
Nurse Practitioner
Medicare: Not Enrolled in Medicare
Practice Location: 6600 Bruceville Rd, Eldercare Adult Medicine F, Sacramento, CA 95823
Phone: 916-688-6862    Fax: 916-973-6682
Ashena Varani, NP
Nurse Practitioner
Medicare: Accepting Medicare Assignments
Practice Location: 3840 Watt Ave, Suite E, Sacramento, CA 95821
Phone: 916-488-6200    Fax: 916-488-6300
Stella Morden, PHD, NP-C
Nurse Practitioner
Medicare: Medicare Enrolled
Practice Location: 1500 21st St, Sacramento, CA 95811
Phone: 916-914-6358    
Yiching Gibson, NP
Nurse Practitioner
Medicare: Medicare Enrolled
Practice Location: 2315 Stockton Blvd, Sacramento, CA 95817
Phone: 916-734-4644    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.